GetTopicDetailResponse(id=9948e87080, topicName=Gazyva, introduction=Gazyva, content=null, image=null, comments=4, allHits=1248, url=https://h5.medsci.cn/topic?id=7870, type=0, isShow=1, status=1, isAdmin=null, adminId=1, adminEncryptionId=1eae1, adminName=小M, createdBy=null, createdName=, createdAvatar=, createdTime=Fri May 29 21:19:53 CST 2020, time=2020-05-29, bannerImg=https://img.medsci.cn/202167/1623032167418_5160405.png, bannerImgH5=https://img.medsci.cn/202167/1623032167418_5160405.png, likes=0, followStatus=false, moduleDTOList=null, tagId=14755, tagList=[TagDto(tagId=14755, tagName=Gazyva)], ipAttribution=, topicAdmin=1, lengthMark=0)
[GetTopicListResponse(id=1460402, encodeId=516014604022c, content=<a href='/topic/show?id=9948e87080' target=_blank style='color:#2F92EE;'>#Gazyva#</a>, objectTitle=FDA授予羅氏的CD20單抗Gazyva在狼瘡性腎炎中的突破性治療指定, objectType=article, longId=179673, objectId=1fca1e96732d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1fca1e96732d, replyNumber=0, likeNumber=83, createdTime=2019-09-20, rootId=0, userName=cy0326, userId=77aa6313597, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1fca1e96732d, moduleTitle=FDA授予羅氏的CD20單抗Gazyva在狼瘡性腎炎中的突破性治療指定, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=1fca1e96732d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1460401, encodeId=edd014604012d, content=<a href='/topic/show?id=9948e87080' target=_blank style='color:#2F92EE;'>#Gazyva#</a>, objectTitle=ASH 2015：Gazyva聯(lián)合苯丁酸氮芥一線治療CLL后4年內(nèi)無需治療, objectType=article, longId=60416, objectId=efc1604161b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=efc1604161b, replyNumber=0, likeNumber=67, createdTime=2015-12-10, rootId=0, userName=cy0326, userId=77aa6313597, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=efc1604161b, moduleTitle=ASH 2015：Gazyva聯(lián)合苯丁酸氮芥一線治療CLL后4年內(nèi)無需治療, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=efc1604161b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1460400, encodeId=9273146040092, content=<a href='/topic/show?id=9948e87080' target=_blank style='color:#2F92EE;'>#Gazyva#</a>, objectTitle=失而復(fù)得，羅氏白血病藥物Gazyvaro重獲NICE批準(zhǔn), objectType=article, longId=43573, objectId=74ac435e3f6, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=74ac435e3f6, replyNumber=0, likeNumber=0, createdTime=2014-12-06, rootId=0, userName=cy0326, userId=77aa6313597, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=74ac435e3f6, moduleTitle=失而復(fù)得，羅氏白血病藥物Gazyvaro重獲NICE批準(zhǔn), moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=74ac435e3f6)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1460399, encodeId=a9f11460399db, content=<a href='/topic/show?id=9948e87080' target=_blank style='color:#2F92EE;'>#Gazyva#</a>, objectTitle=FDA批準(zhǔn)Gazyva與苯丁酸氮芥聯(lián)合治療慢性淋巴細(xì)胞白血病, objectType=article, longId=26357, objectId=0aed2635ee7, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0aed2635ee7, replyNumber=0, likeNumber=104, createdTime=2013-11-09, rootId=0, userName=cy0326, userId=77aa6313597, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0aed2635ee7, moduleTitle=FDA批準(zhǔn)Gazyva與苯丁酸氮芥聯(lián)合治療慢性淋巴細(xì)胞白血病, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=0aed2635ee7)], followStatus=false, userIsMember=false, type=1, lengthMark=0)]
梅斯話題小助手
2020-05-29
